Review Article
A Review of Carcinomas Arising in the Head and Neck Region in HIV-Positive Patients
Table 3
Merkel cell carcinoma in head and neck sites of HIV positive patients (reproduced from Izikson et al. [
61]).
| | Sex | Race | Age (years) | Site | HIV Dx to MCC (years) | CD4 (cells/L) | Viral load (copies/mL) | Treatment | On HAART | Survival (months) |
| | M | NA | 60 | Nose | NA | 329 (2 yrs after Dx) | NA | Mohs XRt | Yes | 24 | | M | NA | 63 | Forehead | 12 | 232 | Undetectable | Mohs | Yes | NA | | F | African black | 36 | Left ear | NA | 63 | 24,000 | WLE | Yes | >9 | | F | African black albino | 25 | Right cheek | NA | 332 | 187,000 | Chemo, XRt, WLE | Yes (after Dx) | 12 | | M | Caucasian | 48 | Scalp | 12 | Normal | Undetectable | WLE, XRt | Yes | >12 |
|
|
Dx: diagnosis, XRt: radiation therapy, NA: not available, Chemo.: chemotherapy, WLE: wide local excision.
|
